RUA LIFE SCIENCES PLC – Interim Results
RNS Number : 2502K RUA Life Sciences PLC 30 June 2026 30 June 2026 RUA Life
RNS Number : 2502K RUA Life Sciences PLC 30 June 2026 30 June 2026 RUA Life
RUA Life Sciences, the holding company of a group of medical device businesses focused on the exploitation of the world’s leading long-term implantable biostable polymer (Elast-EonTM), is pleased to announce the appointments, with immediate effect, to the Board of Dr Caroline Stretton, Group Chief Operating Officer of the Company, and Ian Ardill as a Non-Executive Director and Chair of the Audit Committee.
RUA Life Sciences plc (AIM: RUA.L), the holding company of a group of medical device businesses focused on the exploitation of the world’s leading long-term implantable biostable polymer (Elast-Eon™), is pleased to provide the following update on each of the Group companies for the six months ended 30 September 2020 (the “Period”):
RUA Life Sciences, the holding company of a group of medical device businesses focused on the exploitation of the world’s leading long-term implantable biostable polymer (Elast-EonTM), announces its audited final results for the year ended 31 March 2020.